HIV-1 latent infection in resting CD4+ T lymphocytes is the major obstacle to eradicate the virus in patients after suppressive combination antiretroviral therapy (cART)24, 25, 26. The gene discussed is CD4; the disease is disease arising from reactivation of latent virus.